Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hicks

Showing results (171-180 of 249) with videos related to

Pageof 25
Sort By:
Blood|October 28, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Inna Y Gong, Thomas A Fox, et al.
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical recordJ K Hicks, K R Crews, J M Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living GuidelineLisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Vaccine|June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignanciesSita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
British Journal of Haematology|October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignanciesAbi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Pageof 25

Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Blood|October 28, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Inna Y Gong, Thomas A Fox, et al.
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical recordJ K Hicks, K R Crews, J M Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living GuidelineLisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Vaccine|June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignanciesSita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
British Journal of Haematology|October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignanciesAbi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Pageof 25